Method of treating acne
US9011885B2 · kind B2 · utility
3Cited by
1References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 30, 2014 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Jul 30, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use, as a dermatological or cosmetic medicament, of compounds capable of transiently interacting with the AhR receptor (aryl hydrocarbon receptor) as agents for modulating skin functions such as sebaceous function, skin healing, skin atrophy termed “dermatoporosis”, estrogen deprivation and defense against infection, without inducing other toxic effects of the TCDD type.The compounds that interact with the AhR receptor are chosen in that they have a metabolism favorable to the dissociation of these effects, in particular by virtue of in situ production from a precursor and/or metabolization modulated in situ.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.